HOOKIPA Pharma Inc (NASDAQ:HOOK)

0.5811
Delayed Data
As of 3:57pm ET
 +0.0051 / +0.89%
Today’s Change
0.41
Today|||52-Week Range
2.05
-28.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$47.4M

Company Description

HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.

Contact Information

HOOKIPA Pharma, Inc.
350 Fifth Avenue
New York New York 10118
P:(431) 890-6360
Investor Relations:

Employees

Shareholders

Individual stakeholders9.32%
Mutual fund holders7.50%
Other institutional43.45%

Top Executives

Jörn AldagChief Executive Officer & Director
Christine D. BakerChief Operating Officer
Reinhard KanderaChief Financial Officer & Director
Klaus OrlingerChief Scientific Officer
Roman NecinaChief Technology & Development Officer